Market news

Tipranks Press Release.

Oncology Institute (NASDAQ:TOI) reported second-quarter revenue growth, positive adjusted EBITDA and an expanded pipeline of value-based oncology contracts as the company announced it has rebranded as Starling Oncology. Chief Executive Officer Dan Virnich said the new name reflects the company’s ev

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Company to begin trading on Nasdaq under new ticker symbol “STLN,” replacing “TOI”CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or “the Company”), one of the largest value-based oncology groups in the United States, announced today that it has rebranded to “Starling Oncology, Inc.™.” The Company's common stock will begin trading under the new ticker symbol "STLN” on Nasdaq, effective August 4, 2026, replacing its previous ticker symbol “TOI.” “We've spen

CERRITOS, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release its second quarter 2026 financial results on Thursday, August 6, 2026, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-833-316-1983 or, for international callers, 1-785-838-9310, and referencing Confere

Detailed price information for Biogen Inc (BIIB-Q) from The Globe and Mail including charting and trades.

CERRITOS, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (

The Oncology Institute, Inc. (NASDAQ:TOI) is one of the best medical care facilities stocks to buy according to analysts. It ranks first by average analyst upside in this screen, with analysts seeing roughly 46.8% upside. The latest stronger investor-relevant development came on June 17, when Needham raised its price target on the stock to $7 […]